Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 29,357 shares at $40.39 ($1.2M) on 2023-12-13, disclosed to the SEC on 2023-12-13.
Scheduled sale ($1.2M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.58 | 9,357 | $370K | 31.6% |
| 2 | $39.58 | 9,357 | $370K | 31.6% |
| 3 | $40.47 | 643 | $26K | 2.2% |
| 4 | $40.39 | 10,000 | $404K | 34.5% |
| Total | $39.88 avg | 29,357 | $1.2M | 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |